目的提高乙型肝炎病毒表面抗原在人参愈伤组织细胞中的表达。
Objective To increase the expression level of HBsAg in ginseng callus cells.
乙型肝炎表面抗原-这直接测试是否存在病毒。
Hepatitis B surface Antigen - this tests directly for the presence of virus.
目的建立室内质控参考品以鉴别诊断试剂的质量和控制操作误差，提高乙型肝炎病毒表面抗原的检测准确度。
Objective to establish internal quality control to distinguish the quality of diagnostic Kit and control operate error and improve the accuracy of HBsAg detection.
早期的研究已经显示，对慢性乙型肝炎e抗原阴性的患者进行48周阿德福韦治疗后，获得了临床上的改善。
Early research has shown that a 48-week course of adefovir provides clinical improvements in patients with HBeAg-negative chronic hepatitis B.
乙型肝炎表面抗原a，山羊抗，多克隆。
目的：研究乙型肝炎表面抗原携带者及其子女间的遗传传递。
Objective: to study genetic transmission from the parents with HBsAg to their children.
结论HBV感染PBL可能是慢性乙型肝炎患者外周血淋巴细胞HLA I类抗原表达降低的重要影响因素之一。
Conclusion HBV infected PBL may be one of important factors responsible for affecting the HLA class I antigen expression on PBL in the patients with CHB.
本发明的组合物可以包含乙型肝炎病毒抗原和其他共同给药抗原的组合。
The inventive compositions can comprise a combination of the hepatitis B antigen and other coadministered antigens.
可溶性HLA - I类抗原含量的变化反映了慢性乙型肝炎治疗中患者免疫功能受到调节。
Soluble HLA-I antigen levels may reflect the modulation of the patients immune function through CHB treatment.
目的提高CHO细胞表达的重组乙型肝炎病毒表面抗原的免疫原性。
Objective To improve the immunogenicity of recombinant HBsAg expressed in CHO cells.
此病人除有免淋的全部形态学三联症及异常蛋白血症外，还伴有乙型肝炎表面抗原血症及冷凝集素血症。
The patient not only had all the morphologic triad of IBLD with dysproteinemia but also associated with HBsAg and cold agglutinin existing in his blood.
这表明表面抗原在乙肝病毒感染过程中具有特殊的作用，在乙型肝炎发病机制中扮演了重要的角色。
This unique phenomenon indicates that HBsAg plays an important role in HBV infection and pathogenesis of the disease.
对重组乙型肝炎（乙肝） 病毒前S1抗原（1- 42 ）及核心抗原（1- 144 ）表达的融合蛋白CS1进行了免疫原性的研究分析，以便为探索HBV治疗性疫苗的研制提供实验依据。
The aim of this study was to express a fusion protein of HBV preS1 Ag(1-42) and HBcAg(1-144) and analyze its immunogenicity for further study of HBV therapeutic vaccine.
对重组乙型肝炎（乙肝） 病毒前S1抗原（1- 42 ）及核心抗原（1- 144 ）表达的融合蛋白CS1进行了免疫原性的研究分析，以便为探索HBV治疗性疫苗的研制提供实验依据。
The aim of this study was to express a fusion protein of HBV preS1 Ag(1-42) and HBcAg(1-144) and analyze its immunogenicity for further study of HBV therapeutic vaccine.
应用推荐